The Crohn's & Colitis Foundation of America, American Gastroenterological Association and Janssen Biotech have collaborated to create a new grant program.
The program, which will provide $100,000 per year for three years, will support epigenetic research in inflammatory bowel disease.
"Epigenetic research could be an important part of approaches to understanding the complex interactions between genetic and environmental factors — for example, diet, bacteria, or medications — affecting the development and course of IBD," said Caren A. Heller, MD, MBA, CCFA's Chief Scientific Officer.
Eligible applicants will have completed a PhD within the past seven years, completed a gastroenterology training program and currently hold a position with a North American university. The grant recipient will be selected by an independent panel of AGA and CCFA members.
Applications are due March 15 and the winner will be announced June 15.